Controlled trials demonstrate weight loss with petrelintide in adults, suggesting improved tolerability for weight management.
Petrelintide appeared safe, had a low incidence of GI TEAEs, and resulted in clinically relevant weight loss. These findings support further development of petrelintide as an effective weight-management medication, with potential for improved GI tolerability over existing therapies.
No takes yet. Share an insight, caveat, or question.
OLSEN et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: